Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Nef

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
JACC. Cardiovascular Interventions|April 7, 2018
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry ResultsStephen G Ellis, Tommaso Gori, Patrick W Serruys, et al.
International Journal of Cardiology|March 11, 2020
Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practiceJens Wiebe, Moritz Baquet, Oliver Dörr, et al.
JACC. Cardiovascular Interventions|March 6, 2017
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU RegistrySalvatore Geraci, Hiroyoshi Kawamoto, Giuseppe Caramanno, et al.
Circulation Research|December 19, 2014
Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengtheningLucas N L Van Aelst, Sandra Voss, Paolo Carai, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 2, 2017
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP scoreLuis Ortega-Paz, Davide Capodanno, Tommaso Gori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 13, 2016
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registryLuis Ortega-Paz, Davide Capodanno, Giuseppe Giacchi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 9, 2022
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and balloon-expandable valves: a post hoc analysis from the SOLVE-TAVI trialSerdar Farhan, Georg Stachel, Steffen Desch, et al.
Trials|April 2, 2026
Non-invasive vessel fractional flow reserve versus fractional flow reserve guidance to revascularize intermediate coronary stenosis (LIPSIA-STRATEGY) trial: study protocol for a randomized controlled trialNicolas Majunke, Steffen Desch, Tobias Kister, et al.
European Heart Journal|June 26, 2020
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas ProjectEmanuele Barbato, Marko Noc, Andreas Baumbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2021
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Alaide Chieffo, Giuseppe Tarantini, Christoph Kurt Naber, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
JACC. Cardiovascular Interventions|April 7, 2018
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry ResultsStephen G Ellis, Tommaso Gori, Patrick W Serruys, et al.
International Journal of Cardiology|March 11, 2020
Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practiceJens Wiebe, Moritz Baquet, Oliver Dörr, et al.
JACC. Cardiovascular Interventions|March 6, 2017
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU RegistrySalvatore Geraci, Hiroyoshi Kawamoto, Giuseppe Caramanno, et al.
Circulation Research|December 19, 2014
Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengtheningLucas N L Van Aelst, Sandra Voss, Paolo Carai, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 2, 2017
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP scoreLuis Ortega-Paz, Davide Capodanno, Tommaso Gori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 13, 2016
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registryLuis Ortega-Paz, Davide Capodanno, Giuseppe Giacchi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 9, 2022
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and balloon-expandable valves: a post hoc analysis from the SOLVE-TAVI trialSerdar Farhan, Georg Stachel, Steffen Desch, et al.
Trials|April 2, 2026
Non-invasive vessel fractional flow reserve versus fractional flow reserve guidance to revascularize intermediate coronary stenosis (LIPSIA-STRATEGY) trial: study protocol for a randomized controlled trialNicolas Majunke, Steffen Desch, Tobias Kister, et al.
European Heart Journal|June 26, 2020
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas ProjectEmanuele Barbato, Marko Noc, Andreas Baumbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2021
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Alaide Chieffo, Giuseppe Tarantini, Christoph Kurt Naber, et al.
Pageof 23